Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis-Reference-Cited by-同舟云学术

Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis

Published:2024-06 Issue:6 Volume:9 Page:101487
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Sun Yijia,Saulsberry Loren,Liao Chuanhong,Hedeker Donald,Huo Dezheng

Funder

Breast Cancer Research Foundation

Agency for Health Care Policy and Research

Agency for Healthcare Research and Quality

Publisher

Elsevier BV

Reference56 articles.

1. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial;Bentzen;Lancet Oncol,2008

2. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial;Lancet,2008

3. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials;Haviland;Lancet Oncol,2013

4. Uptake and costs of hypofractionated versus conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013;Bekelman;JAMA,2014

5. Has hypofractionated whole breast radiation therapy become standard of care in the United States? An updated report from National Cancer batabase;Kang;Clin Breast Cancer,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expenditures and Use of Hypofractionated Radiation Therapy Treating Breast Cancer Among Medicare Advantage Enrollees, 2009 to 2017;Advances in Radiation Oncology;2024-09